Adrienne Skinner: Living Life to the Fullest

Thanks to Research

American Association for Cancer Research
Published on Sep 19, 2017
After learning she had metastatic ampullary cancer in 2013, Adrienne Skinner first underwent chemotherapy before turning to a clinical trial of an immunotherapeutic targeting the genetics of her disease. That clinical trial lead to the first ever approval of an anti-cancer therapeutic to treat cancer with that biomarker regardless of where in the body the disease originated. Read Adrienne’s story and those of other survivors in the AACR Cancer Progress Report 2017

Continue reading Original Article

Become Part Of The Solution

Was this helpful? Please help us help patients succeed

World Cholangio Day

20th February 2025
LIGHT AUSTRALIA GREEN

Light Australia Green

Projects you are supporting

Optimal Patient Response (OPR)

From Passenger To Co-Pilot: An Initiative and a carefully choreographed process that enhances healthcare by transforming the standard-of-care into a more comprehensive ‘standard-of-response’ process. At its core are printed Patient Navigator Journals and supporting digital web-app suite, all designed to better equip and empower the patients capacity to effectively respond and survive their diagnosis. A clear, step-by-step process supported by CCF peer-trained Navigators, Coaches, Hospital Ambassadors, and a constructive peer-to-peer community, replacing chaos with calm, and overwhelm with direction.

Support this Project

LAG Project Image-2 – Global Donation Contaner

Light Australia Green

Galvanising Collaboration: The Light Australia Green Initiative is a comprehensive annual campaign focused on raising awareness and driving engagement in bile health and cancer response. Through targeted events, such as hospital-hosted symposiums, landmark illuminations on World Cholangiocarcinoma Day, and an annual conference, the initiative unites key stakeholders to promote collaboration, education and progress in managing bile-related cancers.

Support this Project

BILEflow: Bile Health

BILEflow Stands on its own as a research-driven initiative focused on understanding bile composition and health. Aimed at identifying chronic precancerous conditions, thus providing preventive measures for at risk /family and patient monitoring.

Support this Project

Project CCA Patient Second Opinion Project

BILElink For Patients

Support our CCA-specific BILElink For Patients: A patient-led, AI-assisted central intelligence platform that matches patient diagnoses with patient-endorsed medical professionals, remote 2nd opinions, remote collaborations, and clinical trials by mutation type.

Support this Project

Cholangiocarcinoma Foundation Australia is registered as a charity with the Australian Charities and Not-for-Profits Commission (ACNC). Cholangiocarcinoma Foundation Australia has Deductible Gift Recipient (DGR) status with the Australian Tax Office. Donations over $2 or more are tax-deductible. ABN: 93 665 038 102

Need to Talk

+61 415 153 522

steve@cholangio.org

+61 415 153 522

steve@cholangio.org

Join our updates

Shaping The Future

The Empowered Patient is uniquely positioned and equipped to understand, engage, and succeed by utilizing a process that integrates scientific advancements, evidence-based medicine, and human resilience attributes into a comprehensive response strategy.

Fully embracing the concept of an empowered patient will advance science, reshape the healthcare response, and close the unattended gap between early detection and late-stage diagnosis.

Adrienne Skinner: Living Life to the Fullest